Page last updated: 2024-10-30

leflunomide and Airway Obstruction

leflunomide has been researched along with Airway Obstruction in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Airway Obstruction: Any hindrance to the passage of air into and out of the lungs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peebles, RS1
Moore, ML1
Reichenspurner, H1
Adams, B1
Soni, V1
Brazelton, T1
Shorthouse, R1
Reitz, BA1
Berry, GJ1
Morris, RE1

Other Studies

2 other studies available for leflunomide and Airway Obstruction

ArticleYear
A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy.
    American journal of respiratory cell and molecular biology, 2007, Volume: 37, Issue:4

    Topics: Aged; Airway Obstruction; Animals; Antibodies, Viral; Antiviral Agents; Cattle; Humans; Infant; Isox

2007
Obliterative airway disease after heterotopic tracheal xenotransplantation in a concordant rodent model: pathogenesis and treatment.
    Transplantation proceedings, 1996, Volume: 28, Issue:2

    Topics: Airway Obstruction; Animals; Bronchiolitis Obliterans; Cricetinae; Cyclosporine; Immunosuppressive A

1996